RIL
INBX icon

Rothschild Investment LLC’s Inhibrx INBX Stock Holding History

Rothschild Investment LLC’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56K Buy
27
+5
+23% +$501 ﹤0.01% 2644
2026
Q1 		$1.48K Hold
22
– – ﹤0.01% 2692
2025
Q4 		$1.74K Buy
22
+2
+10% +$136 ﹤0.01% 2449
2025
Q3 		$674 Hold
20
– – ﹤0.01% 2739
2025
Q2 		$285 Buy
20
+19
+1,900% +$246 ﹤0.01% 2867
2025
Q1 		$14 Sell
1
-1
-50% -$14 ﹤0.01% 3012
2024
Q4 		$31 Hold
2
– – ﹤0.01% 2935
2024
Q3 		$31 Sell
2
-1
-33% -$14 ﹤0.01% 2877
2024
Q2 		$43 Buy
+3
New +$47 ﹤0.01% 2789

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Rothschild Investment LLC's INBX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Inhibrx (INBX) stake by 23% in Q2 2026, buying an estimated $501 and bringing the position to 27 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Rothschild Investment LLC first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 46 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Rothschild Investment LLC held 27 shares of Inhibrx worth $2.56K as of Q2 2026.
  • Rothschild Investment LLC bought 5 Inhibrx shares in Q2 2026, an estimated $501.
  • Inhibrx made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2644 holding.
  • Rothschild Investment LLC first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 46 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.